Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Destiny Pharma. Share Price
  4. Destiny Pharma. Share Regulatory News
  5. Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections

Pin to quick picksDestiny Pharma. Regulatory News (DEST)

Destiny Pharma. Information

Share Price Information for Destiny Pharma. (DEST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10.25
DEST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections

21 Nov 2022 14:20

Destiny Pharma PLC Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections 21.11.2022 / 15:19 CET/CEST The issuer is solely responsible for the content of this announcement.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

News Source: News Direct

21.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language:English
Company:Destiny Pharma PLC
United States
ISIN:GB00BDHSP575
EQS News ID:1492837
 
End of NewsEQS News Service

1492837 21.11.2022 CET/CEST

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

12345
Date   Source Headline
9th May 20192:06 pmRNSAppointment of NOMAD and Joint Broker
29th Apr 20192:28 pmRNSPosting of Annual Report and Notice of AGM
9th Apr 20197:00 amRNSFinal Results
5th Apr 20195:06 pmRNSExercise of Options
1st Apr 20193:03 pmRNSExercise of Options
28th Mar 20196:13 pmRNSExercise of Options
27th Mar 20197:00 amRNSMedPharm to develop new XF-drug formulations
22nd Mar 20199:47 amRNSNotice of Results
6th Mar 20196:00 pmRNSExercise of Options
28th Jan 20197:00 amRNSSecond positive phase 1 trial data for XF-73
25th Jan 20197:00 amRNSNew grant awarded under UK-China AMR programme
24th Jan 201911:50 amRNSDestiny Pharma notes UK 5-year action plan on AMR
1st Nov 20187:00 amRNSResearch collaboration with Southampton University
25th Oct 20184:05 pmRNSGrant of Options
25th Oct 20187:00 amRNSDirectorate Change
24th Oct 20187:00 amRNSUK government highlights global threat of AMR
19th Oct 20187:00 amRNSBIA celebrates UK bioscience innovative
26th Sep 20187:00 amRNSDr Jesús González appointed Chief Medical Officer
26th Sep 20187:00 amRNSInterim results for six months ended 30 June 2018
6th Sep 20187:00 amRNSDirectorate Change
26th Jul 20187:00 amRNSPositive Phase 1 skin irritation study with XF-73
17th Jul 20187:00 amRNSResearch collaboration with Aston University
11th Jul 20187:00 amRNSNotice of Results
21st Jun 20187:00 amRNSDirectorate Change
14th Jun 20187:00 amRNSDestiny Pharma notes FDA statement on AMR focus
5th Jun 201812:47 pmRNSDirector/PDMR Shareholding
31st May 201812:30 pmRNSResult of AGM
30th May 20187:00 amRNSDestiny Establishes Scientific Advisory Board
23rd Apr 20187:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20187:00 amRNSDestiny Pharma announces clinical update on XF-73
12th Apr 20187:00 amRNSFinal Results
23rd Mar 20187:00 amRNSNotice of Full Year Results
22nd Mar 20187:00 amRNSAppointment of Joint Broker
15th Mar 20187:00 amRNSFDA Fast Track Designation for lead drug XF-73
26th Feb 20187:00 amRNSDestiny Pharma opens IND ahead of XF-73 US trials
11th Jan 20187:00 amRNSParticipating in Cantor Antibiotics Summit panel
29th Dec 20177:00 amRNSTotal Voting Rights
7th Dec 20179:59 amRNSHolding(s) in Company
1st Dec 20177:01 amRNSChina Medical System Holdings Limited invests £3m
1st Dec 20177:00 amRNSDevelopment and commercial agreement finalised
27th Sep 20177:00 amRNSInterim Results for 6 months ended 30 June 2017
19th Sep 20175:00 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSNotice of Interim Results
6th Sep 20172:31 pmRNSHolding(s) in Company
4th Sep 20177:05 amRNSFramework Agreement with China Medical Systems
4th Sep 20177:00 amRNSAdmission and First Day of Dealings on AIM
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.